Support and Resistance Basics
What is MACD and how to read it?
How RSI can help?
Stock Summary
Top 10 Correlated ETFs
TROW
In the News

Want $1,000 in Monthly Dividend Income? This Ultra-High-Yield Stock Duo Can Make It Happen
Equally splitting $286,000 in capital between these two stocks would generate about $3,000 in dividend income each quarter.

T. Rowe Price's (TROW) July AUM Up 6.1% Sequentially to $1.39T
T. Rowe Price (TROW) witnesses an improvement in July AUM on the back of favorable market performance.

Personal Taxes Vanished From Inflation Reduction Bill
The Inflation Reduction Act, which awaits a House vote, has few if any of the taxes on individuals that Democrats originally called for. The post Personal Taxes Vanished From Inflation Reduction Bill appeared first on Investor's Business Daily.

7 Deep Value Stocks for Income and High Total Returns
Investors have fewer deep value stocks to pick from after the latest rally. Retail investors had enough of the bear market by late June when the S&P 500 bottomed at below 3700.

Got $5000? 3 Top Financial Stocks to Buy for the Long Term
The financial sector offers plenty of compelling places to put some capital to work.

Chantico Global CEO Gina Sanchez offers 3 buys and a bail
Gina Sanchez, Chantico Global CEO, joins ‘The Exchange' to discuss her three investment picks for rate sensitivity against a hawkish Fed.

My Top 10 High Yield Dividend Stocks For August 2022
I present my top 10 High Yield dividend stocks that are poised to offer strong future returns. The annualized rate of return for this watchlist is 21.47% over the past 21 months.

3 Beaten-Down Dividend Growers for Income Investors
The bear market in 2022 has provided opportunities to buy solid companies at a discount. Fears about a recession and rising interest rates have punished equities.

Earn $300 in Quarterly Retirement Dividends With 3 Easy Steps
With the market down close to 20% this year, passive income has become more important.

T. Rowe Price (TROW) Q2 Earnings Miss Estimates, AUM Down Y/Y
Decline in net revenues affects T. Rowe Price's (TROW) Q2 earnings.
Financial details
Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 19.87 | 22.18 | 23.87 | 27.13 | 33.53 | |
Net income per share | 6.21 | 7.59 | 9.05 | 10.37 | 13.47 | |
Operating cash flow per share | 0.95 | 6.69 | 6.47 | 8.39 | 15.09 | |
Free cash flow per share | 0.18 | 5.99 | 5.6 | 7.45 | 14.04 | |
Cash per share | 7.89 | 5.88 | 7.57 | 9.4 | 6.66 | |
Book value per share | 24.15 | 25.29 | 30.17 | 33.68 | 39.43 | |
Tangible book value per share | 21.39 | 22.54 | 27.34 | 30.77 | 29.08 | |
Share holders equity per share | 24.15 | 25.29 | 30.17 | 33.68 | 39.43 | |
Interest debt per share | 0 | 0 | 0 | 0.67 | 0 | |
Market cap | 27.14B | 21.61B | 32.15B | 35.8B | 34.28B | |
Enterprise value | 25.23B | 20.19B | 30.37B | 33.81B | 32.75B | |
P/E ratio | 18.12 | 11.76 | 15.08 | 15.09 | 11.12 | |
Price to sales ratio | 5.66 | 4.02 | 5.72 | 5.77 | 4.47 | |
POCF ratio | 118.25 | 13.34 | 21.11 | 18.66 | 9.93 | |
PFCF ratio | 625.29 | 14.89 | 24.39 | 21.01 | 10.67 | |
P/B Ratio | 4.66 | 3.53 | 4.53 | 4.65 | 3.8 | |
PTB ratio | 4.66 | 3.53 | 4.53 | 4.65 | 3.8 | |
EV to sales | 5.26 | 3.76 | 5.41 | 5.45 | 4.27 | |
Enterprise value over EBITDA | 9.84 | 7.73 | 10.12 | 10.3 | 7.83 | |
EV to operating cash flow | 109.96 | 12.46 | 19.94 | 17.62 | 9.49 | |
EV to free cash flow | 581.44 | 13.91 | 23.04 | 19.84 | 10.19 | |
Earnings yield | 0.06 | 0.09 | 0.07 | 0.07 | 0.09 | |
Free cash flow yield | 0 | 0.07 | 0.04 | 0.05 | 0.09 | |
Debt to equity | 0 | 0 | 0 | 0.02 | 0 | |
Debt to assets | 0.23 | 0.2 | 0.24 | 0.28 | 0.18 | |
Net debt to EBITDA | -0.74 | -0.55 | -0.59 | -0.61 | -0.36 | |
Current ratio | 8.67 | 6.99 | 9.86 | 11.06 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0.15 | 0.88 | 0.71 | 0.81 | 1.12 | |
Dividend Yield | 0.02 | 0.03 | 0.02 | 0.02 | 0.05 | |
Payout ratio | 0.38 | 0.38 | 0.34 | 0.36 | 0.55 | |
Sales general and administrative to revenue | 0.04 | 0.13 | 0.13 | 0.12 | 0.11 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.09 | 0.09 | 0.07 | 0.06 | 0.29 | |
Capex to operating cash flow | -0.81 | -0.1 | -0.13 | -0.11 | -0.07 | |
Capex to revenue | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 | |
Capex to depreciation | -1.3 | -1.06 | -1.07 | -1.13 | -1.17 | |
Stock based compensation to revenue | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | |
Graham number | 58.09 | 65.7 | 78.4 | 88.65 | 109.34 | |
ROIC | 0.29 | 0.32 | 0.26 | 0.26 | 0 | |
Return on tangible assets | 0.22 | 0.26 | 0.25 | 0.24 | 0.35 | |
Graham Net | 2.53 | 1.12 | 0.16 | -0.67 | 0.27 | |
Working capital | 2.18B | 1.69B | 2.18B | 2.74B | 0 | |
Tangible asset value | 5.16B | 5.46B | 6.44B | 7.04B | 6.65B | |
Net current asset value | 749.1M | 409.8M | 200.1M | 62.8M | 326.1M | |
Invested capital | 0 | 0 | 0 | 0.02 | 0 | |
Average receivables | 709.9M | 706.35M | 754.85M | 863.1M | 960.7M | |
Average payables | 201.6M | 208.1M | 201.1M | 187.7M | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 42.39 | 37.34 | 42.01 | 50.76 | 50.35 | |
Days payables outstanding | 43.41 | 37.12 | 32.83 | 26.19 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 8.61 | 9.78 | 8.69 | 7.19 | 7.25 | |
Payables turnover | 8.41 | 9.83 | 11.12 | 13.94 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.26 | 0.3 | 0.3 | 0.31 | 0.34 | |
Capex per share | -0.77 | -0.7 | -0.87 | -0.94 | -1.04 |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 8.5 | 8.61 | 8.72 | 8.28 | 6.67 | |
Net income per share | 3.59 | 3.43 | 3.29 | 2.53 | 1.5 | |
Operating cash flow per share | 3.56 | 5.68 | 1.61 | 4.91 | 2.75 | |
Free cash flow per share | 3.28 | 5.43 | 1.34 | 4.66 | 2.45 | |
Cash per share | 15.49 | 15.07 | 6.77 | 8.88 | 9.33 | |
Book value per share | 34.79 | 36.41 | 40.12 | 40.26 | 39.54 | |
Tangible book value per share | 31.85 | 33.48 | 29.58 | 29.29 | 27.46 | |
Share holders equity per share | 34.79 | 36.41 | 40.12 | 40.26 | 39.54 | |
Interest debt per share | 0.61 | 0.63 | 0 | 0.94 | 0.9 | |
Market cap | 44.92B | 44.63B | 44.22B | 34B | 25.76B | |
Enterprise value | 41.54B | 41.35B | 42.7B | 32.22B | 23.84B | |
P/E ratio | 13.77 | 14.36 | 14.93 | 14.97 | 18.96 | |
Price to sales ratio | 23.28 | 22.84 | 22.54 | 18.25 | 17.02 | |
POCF ratio | 55.64 | 34.63 | 122.4 | 30.82 | 41.3 | |
PFCF ratio | 60.35 | 36.23 | 146.92 | 32.43 | 46.35 | |
P/B Ratio | 5.69 | 5.4 | 4.9 | 3.76 | 2.87 | |
PTB ratio | 5.69 | 5.4 | 4.9 | 3.76 | 2.87 | |
EV to sales | 21.53 | 21.16 | 21.77 | 17.29 | 15.76 | |
Enterprise value over EBITDA | 36.91 | 39.15 | 43.91 | 40.94 | 23.9 | |
EV to operating cash flow | 51.46 | 32.09 | 118.19 | 29.2 | 38.24 | |
EV to free cash flow | 55.81 | 33.57 | 141.86 | 30.73 | 42.91 | |
Earnings yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Free cash flow yield | 0.02 | 0.03 | 0.01 | 0.03 | 0.02 | |
Debt to equity | 0.02 | 0.02 | 0 | 0.02 | 0.02 | |
Debt to assets | 0.3 | 0.28 | 0.18 | 0.18 | 0.17 | |
Net debt to EBITDA | -3 | -3.1 | -1.57 | -2.27 | -1.92 | |
Current ratio | 4.23 | 11.77 | 0 | 4.62 | 7.31 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0.99 | 1.66 | 0.49 | 1.94 | 1.84 | |
Dividend Yield | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.31 | 1.22 | 0.33 | 0.49 | 0.82 | |
Sales general and administrative to revenue | 0.11 | 0.1 | 0.13 | 0.12 | 0.14 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.06 | 0.06 | 0.29 | 0.29 | 0.3 | |
Capex to operating cash flow | -0.08 | -0.04 | -0.17 | -0.05 | -0.11 | |
Capex to revenue | -0.03 | -0.03 | -0.03 | -0.03 | -0.04 | |
Capex to depreciation | -1.25 | -1.1 | -1.14 | -1.01 | -1.24 | |
Stock based compensation to revenue | 0.03 | 0.03 | 0.05 | 0.03 | 0.04 | |
Graham number | 53.04 | 52.97 | 54.52 | 47.83 | 36.51 | |
ROIC | 0.09 | 0.09 | 0 | 0.07 | 0.06 | |
Return on tangible assets | 0.08 | 0.07 | 0.08 | 0.06 | 0.04 | |
Graham Net | 3.6 | 4.13 | 0.27 | 2.03 | 2.93 | |
Working capital | 3.38B | 3.99B | 0 | 2.29B | 2.49B | |
Tangible asset value | 7.23B | 7.6B | 6.65B | 6.59B | 6.23B | |
Net current asset value | 1.05B | 1.17B | 326.1M | 686M | 858.1M | |
Invested capital | 0.02 | 0.02 | 0 | 0.02 | 0.02 | |
Average receivables | 918.85M | 930.55M | 988.9M | 919.5M | 846.35M | |
Average payables | 331.75M | 363.55M | 0 | 417.3M | 389.15M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 42.83 | 43.37 | 48.55 | 44.42 | 45.99 | |
Days payables outstanding | 29.95 | 38.15 | 0 | 50.22 | 52.79 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 2.1 | 2.08 | 1.85 | 2.03 | 1.96 | |
Payables turnover | 3 | 2.36 | 0 | 1.79 | 1.7 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.1 | 0.09 | 0.08 | 0.06 | 0.04 | |
Capex per share | -0.28 | -0.25 | -0.27 | -0.24 | -0.3 |